CCL17 acts as a novel therapeutic target in pathological cardiac hypertrophy and heart failure.
Zhang Y, Ye Y, Tang X, Wang H, Tanaka T, Tian R, Yang X, Wang L, Xiao Y, Hu X, Jin Y, Pang H, Du T, Liu H, Sun L, Xiao S, Dong R, Ferrucci L, Tian Z, Zhang S.
Zhang Y, et al. Among authors: yang x.
J Exp Med. 2022 Aug 1;219(8):e20200418. doi: 10.1084/jem.20200418. Epub 2022 Jun 10.
J Exp Med. 2022.
PMID: 35687056
Free PMC article.